News Endo gives way and withdraws opioid painkiller after FDA pre... Pharma makes decision after FDA intervenes to fight opioid crisis.
News As market declines, Purdue hopes to kick opiate habit Amid opiate crisis, Purdue looks for abuse-deterrent alternatives.
News Amgen's Horizon buyout delivers Sjögren's disease win Amgen's anti-CD40L drug dazodalibep has shown efficacy in Sjögren's in a phase 3 trial, raising hopes for a disease-modifying drug for the disorder.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
